Recently Featured

BIO 2026: CEO Calls for U.S. Biotech Urgency and International Competitiveness

July 7, 2026
SAN DIEGO — Biotechnology is entering one of the most transformative periods in its history. However, according to Biotechnology Innovation Organization (BIO) CEO John Crowley, outdated regulations, rising development costs, and global competition threaten to slow progress unless policymakers act swiftly. At the 2026 BIO International Convention in San Diego, which attracted approximately 20,000 attendees,…

FDA Launches Drug Trials Snapshots Webpage to Enhance Transparency

July 7, 2026
The FDA has introduced the Drug Trials Snapshots webpage, a significant initiative aimed at increasing the availability and transparency of demographic data related to drug trials. This new platform is designed to provide stakeholders, including regulatory professionals, quality assurance experts, and supply chain managers, with critical insights into the diversity of clinical trial participants. Historically,…

Judge Temporarily Blocks Subpoenas in Criminal Probe of Transgender Care at New York Hospitals

July 7, 2026
NEW YORK — A federal judge has temporarily blocked prosecutors in Texas from accessing the medical records of transgender patients treated at New York hospitals, citing concerns over the potential misuse of sensitive information. Judge Katherine Polk Failla emphasized that the subpoenas were part of a broader, improper government initiative aimed at “demonizing and eradicating…

Novel Feeder Cell Line Dramatically Expands NK Cell Production

July 7, 2026
Researchers have developed an engineered feeder cell line, ARH-77, which significantly enhances the production of allogeneic natural killer (NK) cells, a promising avenue for adoptive cell therapy targeting cancer. Traditional production methods have struggled to yield NK cells in sufficient quantities for therapeutic use, with existing cell lines like K562 providing only modest expansion rates.…

Ongoing Cases